Robert P Giugliano Selected Research

Diabetes Mellitus

12/2023	Rationale and Design of the Effect of EVolocumab in PatiEntS at High CArdiovascuLar RIsk WithoUt Prior Myocardial Infarction or Stroke (VESALIUS-CV) Trial.
1/2021	Genetic Risk Score to Identify Risk of Venous Thromboembolism in Patients With Cardiometabolic Disease.
1/2021	Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic Disease.
1/2021	Patients with diabetes mellitus and atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants: meta-analysis of eight outcomes in 58 634 patients across four randomized controlled trials.
1/2020	REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States.
1/2020	Efficacy and safety of edoxaban in patients with diabetes mellitus in the ENGAGE AF-TIMI 48 trial.
1/2020	Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER Trial.
1/2020	Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis.
10/2018	Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
3/2017	Patterns and predictors of lipid-lowering therapy in patients with atherosclerotic cardiovascular disease and/or diabetes mellitus in 2014: Insights from a large US managed-care population.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert P Giugliano Research Topics

Disease

142	Myocardial Infarction 03/2024 - 06/2002
104	Stroke (Strokes) 01/2024 - 04/2005
103	Atrial Fibrillation 01/2024 - 10/2010
93	Hemorrhage 03/2024 - 04/2003
74	Acute Coronary Syndrome 01/2023 - 01/2003
50	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 06/2002
46	ST Elevation Myocardial Infarction 01/2022 - 07/2002
34	Embolism (Embolus) 01/2023 - 10/2010
23	Unstable Angina 01/2023 - 06/2002
22	Ischemic Stroke 02/2024 - 07/2011
17	Heart Failure 01/2023 - 12/2002
17	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 02/2005
16	Thrombosis (Thrombus) 11/2019 - 12/2004
13	Diabetes Mellitus 12/2023 - 08/2013
13	Ischemia 12/2023 - 02/2004
13	Hemorrhagic Stroke 10/2023 - 09/2011
12	Coronary Disease (Coronary Heart Disease) 02/2024 - 09/2008
12	Infarction (Infarctions) 01/2022 - 09/2003
10	Atherosclerosis 12/2023 - 10/2010
10	Intracranial Hemorrhages (Intracranial Hemorrhage) 04/2021 - 04/2003
9	Hypertension (High Blood Pressure) 01/2023 - 02/2005
9	Thromboembolism 01/2019 - 10/2010
8	Peripheral Arterial Disease 02/2024 - 03/2016
8	Body Weight (Weight, Body) 01/2024 - 05/2009
8	Hypercholesterolemia 07/2022 - 06/2011
8	Venous Thromboembolism 01/2020 - 09/2011
7	Neoplasms (Cancer) 03/2024 - 01/2018
7	Non-ST Elevated Myocardial Infarction 01/2022 - 06/2002
5	Transient Ischemic Attack 11/2020 - 08/2014
4	Aortic Valve Stenosis (Aortic Stenosis) 02/2024 - 03/2017
4	Reperfusion Injury 04/2016 - 11/2009
3	Prediabetic State (Prediabetes) 05/2024 - 06/2013
3	Hypertriglyceridemia 04/2024 - 12/2021
3	Genetic Risk Score 01/2023 - 01/2020
3	Renal Insufficiency (Renal Failure) 01/2020 - 05/2008
3	Heart Valve Diseases (Valvular Heart Disease) 01/2018 - 03/2017
3	Obesity 08/2014 - 12/2012

Drug/Important Bio-Agent (IBA)

83	Warfarin (Coumadin)FDA LinkGeneric 01/2024 - 11/2009
58	AnticoagulantsIBA 01/2024 - 06/2007
58	edoxabanIBA 01/2023 - 10/2010
46	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2023 - 09/2008
42	evolocumabIBA 02/2024 - 01/2012
41	LDL CholesterolIBA 12/2023 - 09/2008
37	Factor Xa (Coagulation Factor Xa)IBA 01/2023 - 10/2010
36	oxidized low density lipoproteinIBA 12/2023 - 09/2008
33	Vitamin K FDA Link 01/2024 - 10/2010
25	Glycoproteins (Glycoprotein)IBA 01/2020 - 02/2004
23	Ezetimibe (Zetia)FDA Link 01/2023 - 08/2014
19	LipidsIBA 05/2024 - 09/2008
19	Eptifibatide (Integrilin)FDA Link 04/2017 - 04/2003
16	Simvastatin (Zocor)FDA LinkGeneric 01/2023 - 11/2008
15	CreatinineIBA 01/2023 - 12/2002
14	Proprotein Convertase 9IBA 12/2023 - 08/2013
14	Simvastatin Drug Combination Ezetimibe (Vytorin)FDA Link 01/2023 - 11/2008
14	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 05/2006
13	Biomarkers (Surrogate Marker)IBA 01/2023 - 02/2004
13	Clopidogrel (Plavix)FDA Link 01/2022 - 07/2006
12	Factor Xa InhibitorsIBA 03/2019 - 10/2010
11	Enoxaparin (Lovenox)FDA LinkGeneric 07/2013 - 06/2002
10	N(4)-oleylcytosine arabinosideIBA 01/2024 - 08/2014
9	Tenecteplase FDA Link 07/2009 - 04/2003
8	CholesterolIBA 01/2022 - 01/2012
7	TroponinIBA 01/2022 - 12/2004
7	N(2)-(3-trifluoromethylphenyl)guanineIBA 04/2014 - 05/2004
7	Prasugrel Hydrochloride FDA Link 11/2013 - 03/2009
7	Heparin (Liquaemin)FDA LinkGeneric 07/2009 - 01/2003
6	C-Reactive ProteinIBA 05/2024 - 10/2018
6	Triglycerides (Triacylglycerol)IBA 05/2024 - 08/2014
6	HDL CholesterolIBA 04/2024 - 10/2011
6	Lipoprotein(a)IBA 02/2024 - 08/2013
6	omega-Chloroacetophenone (Mace)IBA 02/2024 - 12/2019
6	RivaroxabanIBA 01/2023 - 09/2013
6	eicosapentaenoic acid ethyl esterIBA 01/2022 - 01/2020
6	TicagrelorIBA 01/2022 - 01/2010
6	AntithrombinsIBA 04/2018 - 08/2004
5	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 01/2012
5	ApolipoproteinsIBA 05/2024 - 11/2016
5	Monoclonal AntibodiesIBA 12/2023 - 01/2012
5	apixabanIBA 01/2023 - 08/2014
5	Tirofiban (Aggrastat)FDA Link 11/2020 - 02/2004
5	Dabigatran FDA Link 01/2018 - 09/2011
5	MB Form Creatine KinaseIBA 04/2016 - 09/2003
4	Growth Differentiation Factor 15IBA 01/2023 - 10/2010
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2007
4	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 04/2017
4	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 01/2013
4	Hemoglobins (Hemoglobin)IBA 01/2019 - 04/2005
4	Fibrinolytic Agents (Antithrombotic Agents)IBA 07/2016 - 01/2003
4	Platelet Membrane Glycoprotein IIbIBA 01/2012 - 01/2008
3	HDL LipoproteinsIBA 01/2020 - 08/2014
3	arginyl- 2,'6'- dimethyltyrosyl- lysyl- phenylalaninamideIBA 04/2016 - 04/2013
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2014 - 03/2009

Therapy/Procedure

98	Therapeutics 12/2023 - 04/2003
36	Percutaneous Coronary Intervention 03/2024 - 01/2003
17	Thrombolytic Therapy 04/2011 - 01/2003
9	Secondary Prevention 01/2023 - 01/2013
9	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2023 - 07/2007
7	Drug Tapering 12/2022 - 05/2012
5	Patient Readmission 06/2015 - 02/2004
5	Stents 10/2014 - 03/2011